https://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/Amgen-Announces-Top-Line-Results-From-Phase-3-KYPROLIS-Carfilzomib-CLARION-Study-In-Newly-Diag-23118337/?utm_source=telegram&utm_medium=social&utm_campaign=share